Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patients.
Koda M, Murawaki Y, Hirooka Y, Kitamoto M, Ono M, Sakaeda H, Joko K, Sato S, Tamaki K, Yamasaki T, Shibata H, Shimoe T, Matsuda T, Toshikuni N, Fujioka S, Ohmoto K, Nakamura S, Kariyama K, Aikata H, Kobayashi Y, Tsutsui A. Koda M, et al. Among authors: kobayashi y. Hepatol Res. 2012 Nov;42(11):1058-64. doi: 10.1111/j.1872-034X.2012.01025.x. Epub 2012 May 14. Hepatol Res. 2012. PMID: 22583706
Application of radiofrequency ablation for the treatment of metastatic liver cancers.
Nouso K, Kobayashi Y, Nakamura S, Uematsu S, Shiraga K, Iwadou S, Araki Y, Taniguchi H, Tanaka H, Toshikuni N, Kaneyoshi T, Ikeda H, Fujioka S, Osawa T, Iwasaki Y, Shiraha H, Yamamoto K. Nouso K, et al. Among authors: kobayashi y. Hepatogastroenterology. 2010 Jan-Feb;57(97):117-20. Hepatogastroenterology. 2010. PMID: 20422885
Efficacy of sorafenib beyond first progression in patients with metastatic hepatocellular carcinoma.
Miyahara K, Nouso K, Morimoto Y, Takeuchi Y, Hagihara H, Kuwaki K, Onishi H, Ikeda F, Miyake Y, Nakamura S, Shiraha H, Takaki A, Iwadou S, Kobayashi Y, Takaguchi K, Takuma Y, Takabatake H, Sakaguchi K, Yamamoto K; Okayama Liver Cancer Group. Miyahara K, et al. Among authors: kobayashi y. Hepatol Res. 2014 Mar;44(3):296-301. doi: 10.1111/hepr.12123. Epub 2013 Apr 29. Hepatol Res. 2014. PMID: 23607549
Prevention of vagotonia and pain during radiofrequency ablation of liver tumors.
Nakamura S, Nouso K, Onishi H, Kuwaki K, Hagihara H, Takeuchi Y, Wada N, Morimoto Y, Miyahara K, Yasunaka T, Ikeda F, Miyake Y, Kobayashi Y, Shiraha H, Ishikawa S, Takaki A, Yamamoto K. Nakamura S, et al. Among authors: kobayashi y. Hepatol Res. 2014 Dec;44(13):1367-70. doi: 10.1111/hepr.12321. Epub 2014 Apr 2. Hepatol Res. 2014. PMID: 24593141
Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma.
Onishi T, Nouso K, Higashi T, Toshikuni N, Nakatsukasa H, Kobayashi Y, Uemura M, Yumoto E, Fujiwara K, Sato S, Nakamura S, Yokoyama J, Hanafusa T, Shiratori Y. Onishi T, et al. Among authors: kobayashi y. J Gastroenterol Hepatol. 2003 Oct;18(10):1168-74. doi: 10.1046/j.1440-1746.2003.03137.x. J Gastroenterol Hepatol. 2003. PMID: 12974904
Hepatocellular carcinoma occurring in hepatobiliary fibropolycystic disease.
Kinugasa H, Nouso K, Kobayashi Y, Yasunaka T, Onishi H, Nakamura S, Shiraha H, Takayama H, Toshimori J, Kuwaki K, Hagihara H, Miyake Y, Ikeda F, Takaki A, Kobashi H, Yamamoto K. Kinugasa H, et al. Among authors: kobayashi y. Hepatol Res. 2011 Mar;41(3):277-81. doi: 10.1111/j.1872-034X.2010.00761.x. Hepatol Res. 2011. PMID: 21338456
10,543 results
You have reached the last available page of results. Please see the User Guide for more information.